All MSC‐BMP4 donors failed to produce a significant impact of the non‐stem‐like population (selected by the removal of mitogens) (Figure 3c), confirming the preferential effects of the platform on the stem‐like population of GBM. This evidence concerns the gene BMP4 and glioblastoma.